Cizzle Biotechnology Holdings PLC (LSE:CIZ) — Stock Price
Cizzle Biotechnology Holdings PLC (LSE:CIZ) is currently trading at GBX1.70 GBX, up 0.00% today. Over the past 52 weeks, shares have ranged between GBX1.29 and GBX3.65. This page tracks Cizzle Biotechnology Holdings PLC's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Cizzle Biotechnology Holdings PLC stock valuation.
Cizzle Biotechnology Holdings PLC (CIZ) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Cizzle Biotechnology Holdings PLC's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Cizzle Biotechnology Holdings PLC Income Statement — Revenue, Profit & Earnings by Year
Cizzle Biotechnology Holdings PLC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | GBX0.00 | GBX0.00 | GBX0.00 | GBX0.00 | GBX0.00 |
| Cost of Revenue | — | — | GBX0.00 | GBX0.00 | GBX0.00 |
| Gross Profit | — | — | GBX0.00 | GBX0.00 | GBX0.00 |
| Research & Development | GBX213.00 | GBX214.00 | GBX280.00K | GBX161.00K | — |
| SG&A | GBX876.00 | GBX976.00 | GBX381.00K | GBX266.00K | GBX229.00K |
| Total Operating Expenses | GBX1.09K | GBX1.19K | GBX963.00K | GBX851.00K | GBX229.00K |
| Operating Income | GBX-878.00K | GBX-976.00K | GBX-963.00K | GBX2.26 Million | GBX-229.00K |
| EBITDA | — | GBX-695.00 | GBX-963.00K | GBX-851.00K | GBX-306.00K |
| EBIT | — | GBX-1.67K | GBX-963.00K | GBX2.26 Million | GBX-306.01K |
| Interest Expense | — | — | — | GBX6.21 Million | GBX0.00 |
| Income Before Tax | GBX-2.19 Million | GBX-1.76 Million | GBX-963.00K | GBX-3.96 Million | GBX-306.00K |
| Income Tax Expense | GBX-21.00K | GBX-46.00K | GBX-51.00K | GBX-37.00K | GBX-77.00K |
| Net Income | GBX-2.17K | GBX-1.72K | GBX-912.00K | GBX-3.92 Million | GBX-306.00K |
Cizzle Biotechnology Holdings PLC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Cizzle Biotechnology Holdings PLC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | GBX492.00K | GBX1.69 Million | GBX2.79 Million | GBX1.16 Million | GBX90.00K |
| Total Current Assets | GBX492.00K | GBX1.69 Million | GBX705.00K | GBX955.00K | GBX90.00K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | GBX22.00K | GBX1.41 Million | — | — | — |
| Net Receivables | GBX103.00K | GBX136.00K | GBX227.00K | GBX80.00K | GBX6.00K |
| Inventory | GBX2.00K | GBX-1.55 Million | GBX-227.00 | GBX-80.00 | GBX-3.00 |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | GBX410.00K | GBX186.00K | GBX145.00K | GBX218.00K | GBX58.00K |
| Total Current Liabilities | GBX410.00K | GBX186.00K | GBX145.00K | GBX218.00K | GBX58.00K |
| Long-term Debt | — | — | — | — | — |
| Net Debt | GBX-365.00K | GBX-144.00K | GBX-478.00K | GBX-875.00K | GBX-83.99K |
| Total Stockholder Equity | GBX82.00K | GBX1.51 Million | GBX2.64 Million | GBX937.00K | GBX32.00K |
| Retained Earnings | GBX-10.04 Million | GBX-7.87 Million | GBX-6.15 Million | GBX-5.52 Million | GBX-22.37 Million |
Cizzle Biotechnology Holdings PLC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Cizzle Biotechnology Holdings PLC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-358.00K | GBX-639.00K | GBX-872.00K | GBX-1.01 Million | GBX-294.00K |
| Capital Expenditures | GBX0.00 | GBX0.00 | GBX0.00 | GBX200.00K | GBX0.00 |
| Free Cash Flow | GBX-358.00K | GBX-639.00K | GBX-872.00K | GBX-1.21 Million | GBX-294.00K |
| Investing Cash Flow | — | — | GBX-120.00K | GBX-154.00K | GBX-154.00K |
| Financing Cash Flow | GBX579.00K | GBX305.00K | GBX595.00K | GBX2.03 Million | GBX10.00 |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | GBX162.00K | GBX307.00K | GBX148.00K | GBX310.00K | — |
| Depreciation | — | — | — | — | — |
| Change in Cash | GBX221.00K | GBX-334.00K | GBX-397.00K | GBX868.00K | GBX-294.00K |
Cizzle Biotechnology Holdings PLC Earnings History — EPS Actual vs. Analyst Estimates
Track Cizzle Biotechnology Holdings PLC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 06, 2026 | 0.00 | 0.00 | — |
| Sep 30, 2025 | 0.00 | 0.00 | — |
| Apr 30, 2025 | 0.00 | 0.00 | — |
| Sep 30, 2024 | 0.00 | 0.00 | — |
| Apr 27, 2023 | 0.00 | 0.00 | — |
| Sep 28, 2022 | 0.00 | 0.00 | — |
| May 30, 2022 | -0.01 | 0.00 | — |
| Sep 30, 2021 | -0.01 | 0.00 | — |